Funding for this research was provided by:
State of Connecticut Department of Public Health (DPH log # 2021-0071-3)
Received: 10 June 2022
Accepted: 21 February 2023
First Online: 13 March 2023
: This work was determined to be a public health surveillance activity by the Yale Institutional Review Board and exempt from review (ID: 200003233).
: Not applicable.
: AIK serves as an expert panel member for Reckitt Global Hygiene Institute, scientific advisory board member for Revelar Biotherapeutics and a consultant for Tata Medical and Diagnostics and Regeneron Pharmaceuticals, and has received grants from Merck, Regeneron Pharmaceuticals and Tata Medical and Diagnostics for research related to COVID-19, all of which are outside the scope of the submitted work. Other authors declare no conflict of interest.